Whether you are new to the tobacco industry or merely launching a new product as an addition to one of your existing ranges, you need to follow the various application processes to ensure you get the necessary approval according to stipulations in the valid tobacco directive you need to adhere to. While this process can be overwhelming an insufficient completion of forms can slow down the process, it doesn’t need to be the case when you rely on a trusted partner to provide you with the necessary support. It would be a partner such as a team at CSUR.

“According to the local tobacco directive, every company who wants to market any kind of product or ENDS needs to apply for the necessary authorisation to do so from the FDA. The process requires various steps before its final approval. These steps include the completion of a premarket tobacco application, the process of a modified risk application, as well as the fulfillment of several behavioral research program requirements. Our team assists with all these processes,” says Sophie Notley, a research fellow at the leading name in the industry, CSUR.

Notley further expands on the finer details of such a behavioral research program that includes several steps. It entails the assessment of several risks as well as the benefits the product holds to the general population and their general health. The research also entails the assessment of how the product will either influence users to quit using tobacco products or encourage them to continue to do so. The latter includes research to see if the product will encourage previously non-smokers to start using. Packaging of these products is also of vital importance as it might create an increased appeal to start using the product. A lot of the value the team at CSUR contributes to your business depends on the extensive market research they have been doing for more than a decade and the wealth of experience they have in the specific field.

“We are also involved in post-market surveillance. This surveillance is a requirement of the FDA and the process aims to determine how accurate the claims were that the manufacturer made in their initial application regarding how their product would reduce harm in respect of their product range. In the end, all we do and all that the FDA requires has at the core the same purpose, to reduce harm through quality products,” Notley concludes.

About Us
Our story starts in 1994 when we were part of the University of Glasgow and involved in substance research. From here we moved on to become more involved in developing behavior-focused science intending to put relevant regulation in place for these substances in 2011. Our team is involved in various research projects alongside the governing bodies of the substances we research and together we work towards optimising the risk and harm related to the use of any combustible tobacco products. Visit our website https://www.csures.com/ or contact us via phone or email and explore more about the research we do and how we can help you.